BlackRock
CELL

BlackRock’s PhenomeX Inc. Common Stock CELL Stock Holding History

BlackRock’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,386,633
Closed -$679K – 5562
2023
Q2 		$679K Sell
1,386,633
-3,449,200
-71% -$2.82M ﹤0.01% 4397
2023
Q1 		$5.61M Buy
4,835,833
+191,004
+4% +$349K ﹤0.01% 3579
2022
Q4 		$12.4M Sell
4,644,829
-312,069
-6% -$823K ﹤0.01% 3288
2022
Q3 		$14.2M Sell
4,956,898
-48,661
-1% -$207K ﹤0.01% 3234
2022
Q2 		$24.9M Buy
5,005,559
+453,607
+10% +$2.38M ﹤0.01% 2968
2022
Q1 		$32.4M Buy
4,551,952
+11,467
+0.3% +$94.9K ﹤0.01% 2857
2021
Q4 		$82.5M Buy
4,540,485
+831,935
+22% +$18M ﹤0.01% 2339
2021
Q3 		$72.5M Buy
3,708,550
+325,170
+10% +$12.4M ﹤0.01% 2413
2021
Q2 		$152M Buy
3,383,380
+2,300,058
+212% +$107M ﹤0.01% 1979
2021
Q1 		$54.4M Buy
1,083,322
+306,184
+39% +$20.9M ﹤0.01% 2559
2020
Q4 		$69.5M Buy
777,138
+132,589
+21% +$11.2M ﹤0.01% 2277
2020
Q3 		$49.2M Buy
+644,549
New +$40.9M ﹤0.01% 2313

Other funds holding CELL

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock's CELL Position: Q3 2023 in Review

BlackRock sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 1,386,633 shares — an estimated $679K sold.

BlackRock first reported a position in CELL in Q3 2020 and held it in 12 quarters. The position peaked at $152M in Q2 2021. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • BlackRock reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • BlackRock sold 1,386,633 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $679K.
  • BlackRock first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 12 quarters.
  • BlackRock's PhenomeX Inc. Common Stock position peaked at $152M in Q2 2021.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on BlackRock's 13F filing for Q3 2023, filed 13 Nov 2023.